Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Baihui Li

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Journal of Cancer|February 3, 2025
Risk Prediction of Myelosuppression Following First-line Chemotherapy in Colorectal CancerYanyuan Du, Yuming Liu, Ruiying Fang, et al.
Acta Biochimica Et Biophysica Sinica|May 29, 2026
USP18-stabilized ELF3 drives glycolysis and malignant progression in lung adenocarcinomaYu Zeng, Yeran Yi, Qinfen Zhang, et al.
Cell Death & Disease|May 6, 2022
CD4<sup>+</sup> T cells are required to improve the efficacy of CIK therapy in non-small cell lung cancerShaochuan Liu, Yuan Meng, Liang Liu, et al.
Pain and Therapy|November 17, 2024
Repetitive Transcranial Magnetic Stimulation: Is it an Effective Treatment for Cancer Pain?Yanyuan Du, Yaoyuan Li, Jieqing Hu, et al.
Scientific Reports|March 2, 2023
Risk factors for totally implantable access ports-associated thrombosis in pediatric oncology patientsYingxia Lan, Liuhong Wu, Jin Guo, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Journal of Cancer|February 3, 2025
Risk Prediction of Myelosuppression Following First-line Chemotherapy in Colorectal CancerYanyuan Du, Yuming Liu, Ruiying Fang, et al.
Acta Biochimica Et Biophysica Sinica|May 29, 2026
USP18-stabilized ELF3 drives glycolysis and malignant progression in lung adenocarcinomaYu Zeng, Yeran Yi, Qinfen Zhang, et al.
Cell Death & Disease|May 6, 2022
CD4<sup>+</sup> T cells are required to improve the efficacy of CIK therapy in non-small cell lung cancerShaochuan Liu, Yuan Meng, Liang Liu, et al.
Pain and Therapy|November 17, 2024
Repetitive Transcranial Magnetic Stimulation: Is it an Effective Treatment for Cancer Pain?Yanyuan Du, Yaoyuan Li, Jieqing Hu, et al.
Scientific Reports|March 2, 2023
Risk factors for totally implantable access ports-associated thrombosis in pediatric oncology patientsYingxia Lan, Liuhong Wu, Jin Guo, et al.
Pageof 4